...
首页> 外文期刊>Applied Microbiology and Biotechnology >Growth-associated synthesis of recombinant human glucagon and human growthhormone in high-cell-density cultures of Escherichia coli
【24h】

Growth-associated synthesis of recombinant human glucagon and human growthhormone in high-cell-density cultures of Escherichia coli

机译:重组人胰高血糖素和人生长激素在大肠杆菌高细胞密度培养中的生长相关合成

获取原文
获取原文并翻译 | 示例

摘要

Synthesis of two recombinant proteins (human glucagon and human growth hormone) was investigated in fed-batch cultures at high cell concentrations of recombinant Escherichia coli. The glucose-limited growth was achieved without accumulation of metabolic by-products and hence the cellular environment is presumed invariable during growth and recombinant protein synthesis. Via exponential feeding in the two-phase fed-batch operation, the specific cell growth rate was successfully controlled at the desired rates and the fed-batch mode employed is considered appropriate for examining the correlation between the specific growth rate and the efficiency of recombinant product formation in the recombinant E. coli strains. The two recombinant proteins were expressed as fusion proteins and the concentration in the culture broth was increased to 15 g fusion growth hormone l(-1) and 7 g fusion glucagon l(-1). The fusion growth hormone was initially expressed as soluble protein but seemed to be gradually aggregated into inclusion bodies as the expression level increased, whereas the synthesized fusion glucagon existed as a cytoplasmic soluble protein during the whole induction period. The stressful conditions of cultivation employed (i.e. high-cell-density cultivation at low growth rate) may induce the increased production of various host-derived chaperones and thereby enhance the folding efficiency of synthesized heterologous proteins, The synthesis of the recombinant fusion proteins was strongly growth-dependent and more efficient at a higher specific growth rate. The mechanism linking specific growth rate with recombinant protein productivity is likely to be related to the change in cellular ribosomal content.
机译:在高细胞浓度的重组大肠杆菌的补料分批培养中研究了两种重组蛋白(人胰高血糖素和人生长激素)的合成。葡萄糖限制的生长得以实现而没有代谢副产物的积累,因此推测在生长和重组蛋白合成过程中细胞环境是不变的。通过两阶段补料分批操作中的指数补料,成功地将特定的细胞生长速率控制在所需的速率,并且所采用的补料分批模式被认为适合检查比生长速率与重组产物效率之间的相关性在重组大肠杆菌菌株中形成。将两种重组蛋白表达为融合蛋白,并将培养液中的浓度增加至15 g融合生长激素l(-1)和7 g融合胰高血糖素l(-1)。融合生长激素最初以可溶性蛋白表达,但随着表达水平的增加似乎逐渐聚集成包涵体,而合成的融合胰高血糖素则在整个诱导期以细胞质可溶性蛋白的形式存在。所采用的胁迫培养条件(即低生长速率下的高细胞密度培养)可诱导各种宿主衍生的伴侣蛋白的产量增加,从而提高合成的异源蛋白的折叠效率。以增长为依托,以更高的特定增长率更有效。将特定生长速率与重组蛋白生产率联系起来的机制可能与细胞核糖体含量的变化有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号